Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verheijen

Showing results (921-930 of 1,005) with videos related to

Pageof 101
Sort By:
European Journal of Human Genetics : EJHG|February 16, 2012
COL4A2 mutation associated with familial porencephaly and small-vessel diseaseElly Verbeek, Marije E C Meuwissen, Frans W Verheijen, et al.
Annals of Surgical Oncology|October 5, 2021
Laparoscopic Versus Robot-Assisted Versus Transanal Low Anterior Resection: 3-Year Oncologic Results for a Population-Based Cohort in Experienced CentersT A Burghgraef, J C Hol, M L Rutgers, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
The longevity effects of reduced IGF-1 signaling depend on the stability of the mitochondrial genomeSarah J Shemtov, Eric McGann, Lucy Carrillo, et al.
Nature Communications|March 21, 2023
Evolutionary conservation of the fidelity of transcriptionClaire Chung, Bert M Verheijen, Zoe Navapanich, et al.
European Journal of Cancer (Oxford, England : 1990)|September 13, 2006
Alterations in the p53 pathway and prognosis in advanced ovarian cancer: a multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865)J A Green, E M J J Berns, C Coens, et al.
Neurobiology of Aging|September 15, 2018
Paradoxical effects of mutant ubiquitin on Aβ plaque formation in an Alzheimer mouse modelBert M Verheijen, Jo A A Stevens, Romina J G Gentier, et al.
International Journal of Cancer|December 31, 2010
Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive womenRenée M Overmeer, Jacqueline A Louwers, Chris J L M Meijer, et al.
Cancer Research|January 14, 2010
Beyond rapalog therapy: preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2Ker Yu, Celine Shi, Lourdes Toral-Barza, et al.
European Journal of Cancer (Oxford, England : 1990)|September 21, 2010
Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trialLeen Verleye, Petronella B Ottevanger, Gunnar B Kristensen, et al.
Toxicology Letters|December 18, 2021
iPSC-derived cortical neurons to study sporadic Alzheimer disease: A transcriptome comparison with post-mortem brain samplesM C T Verheijen, J Krauskopf, F Caiment, et al.
Pageof 101

Showing results (921-930 of 1,005) with videos related to

Sort By:
Pageof 101
European Journal of Human Genetics : EJHG|February 16, 2012
COL4A2 mutation associated with familial porencephaly and small-vessel diseaseElly Verbeek, Marije E C Meuwissen, Frans W Verheijen, et al.
Annals of Surgical Oncology|October 5, 2021
Laparoscopic Versus Robot-Assisted Versus Transanal Low Anterior Resection: 3-Year Oncologic Results for a Population-Based Cohort in Experienced CentersT A Burghgraef, J C Hol, M L Rutgers, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
The longevity effects of reduced IGF-1 signaling depend on the stability of the mitochondrial genomeSarah J Shemtov, Eric McGann, Lucy Carrillo, et al.
Nature Communications|March 21, 2023
Evolutionary conservation of the fidelity of transcriptionClaire Chung, Bert M Verheijen, Zoe Navapanich, et al.
European Journal of Cancer (Oxford, England : 1990)|September 13, 2006
Alterations in the p53 pathway and prognosis in advanced ovarian cancer: a multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865)J A Green, E M J J Berns, C Coens, et al.
Neurobiology of Aging|September 15, 2018
Paradoxical effects of mutant ubiquitin on Aβ plaque formation in an Alzheimer mouse modelBert M Verheijen, Jo A A Stevens, Romina J G Gentier, et al.
International Journal of Cancer|December 31, 2010
Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive womenRenée M Overmeer, Jacqueline A Louwers, Chris J L M Meijer, et al.
Cancer Research|January 14, 2010
Beyond rapalog therapy: preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2Ker Yu, Celine Shi, Lourdes Toral-Barza, et al.
European Journal of Cancer (Oxford, England : 1990)|September 21, 2010
Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trialLeen Verleye, Petronella B Ottevanger, Gunnar B Kristensen, et al.
Toxicology Letters|December 18, 2021
iPSC-derived cortical neurons to study sporadic Alzheimer disease: A transcriptome comparison with post-mortem brain samplesM C T Verheijen, J Krauskopf, F Caiment, et al.
Pageof 101